Cardinal Health, Inc (CAH) concluded trading on Thursday at a closing price of $117.46, with 3.0 million shares of worth about $352.21 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 16.75% during that period and on December 12, 2024 the price saw a gain of about 0.03%. Currently the company’s common shares owned by public are about 242.00M shares, out of which, 241.34M shares are available for trading.
Stock saw a price change of -4.38% in past 5 days and over the past one month there was a price change of -4.90%. Year-to-date (YTD), CAH shares are showing a performance of 16.53% which increased to 8.83% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $93.17 but also hit the highest price of $126.23 during that period. The average intraday trading volume for Cardinal Health, Inc shares is 2.04 million. The stock is currently trading -3.19% below its 20-day simple moving average (SMA20), while that difference is up 0.60% for SMA50 and it goes to 9.12% higher than SMA200.
Cardinal Health, Inc (NYSE: CAH) currently have 242.00M outstanding shares and institutions hold larger chunk of about 88.83% of that.
The stock has a current market capitalization of $28.43B and its 3Y-monthly beta is at 0.64. PE ratio of stock for trailing 12 months is 22.83, while it has posted earnings per share of $5.15 in the same period. Its PEG reads 1.76 and has Quick Ratio of 0.50. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for CAH, volatility over the week remained 2.36% while standing at 2.24% over the month.
Stock’s fiscal year EPS is expected to rise by 3.77% while it is estimated to increase by 10.80% in next year. EPS is likely to grow at an annualized rate of 13.00% for next 5-years, compared to annual growth of -5.30% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Mizuho on December 04, 2024 offering an Outperform rating for the stock and assigned a target price of $139 to it. Coverage by Leerink Partners stated Cardinal Health, Inc (CAH) stock as an Outperform in their note to investors on February 26, 2024, suggesting a price target of $125 for the stock. On February 09, 2024, Argus Upgrade their recommendations, while on January 03, 2024, Barclays Initiated their ratings for the stock with a price target of $117. Stock get an Underweight rating from Wells Fargo on December 14, 2023.
